| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |